Can tech improve health care’s value proposition?
Editor’s word: A livestream of the dialog shall be embedded under at 1 p.m. ET.
Every week, STAT+ subscribers get entry to unique conversations with biotech, pharma, and well being tech leaders. This week, STAT well being tech correspondent Erin Brodwin shall be joined by Glen Tullman, govt chairman and CEO of Transcarent. Coming off the success of Livongo, Tullman will focus on his new concepts for revamping employer-based well being, and naturally be taking your questions reside.
Unlock this text by subscribing to STAT+ and revel in your first 30 days free!
GET STARTED
What’s it?
STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, coverage, and life science protection and evaluation.
Our award-winning group covers information on Wall Road, coverage developments in Washington, early science breakthroughs and medical trial outcomes, and well being care disruption in Silicon Valley and past.
What’s included?
- Each day reporting and evaluation
- Probably the most complete trade protection from a powerhouse group of reporters
- Subscriber-only newsletters
- Each day newsletters to transient you on crucial trade information of the day
- STAT+ Conversations
- Weekly alternatives to have interaction with our reporters and main trade specialists in reside video conversations
- Unique trade occasions
- Premium entry to subscriber-only networking occasions across the nation
- One of the best reporters within the trade
- Probably the most trusted and well-connected newsroom within the well being care trade
- And way more
- Unique interviews with trade leaders, profiles, and premium instruments, like our CRISPR Trackr.
